Logo
x

Search

Subscribe Now

Lung Disease

Roche's Actemra/RoActemra (tocilizumab) Receives the US FDA's Approval as the First Biologic for Systemic Sclerosis-Associated Interstitial Lung Disease

Roche's Actemra/RoActemra (tocilizumab) Receives the US FDA's Approval as the First Biologic for Systemic Sclerosis-Associated Int...

  • March 5, 2021
Genentech's Esbriet (pirfenidone) Receives FDA's Breakthrough Therapy Designation for Unclassifiable Interstitial Lung Disease

Genentech's Esbriet (pirfenidone) Receives FDA's Breakthrough Therapy Designation for Unclassifiable Interstitial Lung Disease

  • March 3, 2020
Boehringer Ingelheim's Nintedanib Receives CHMP's Positive Opinion to Treat Systemic Sclerosis-Associated Interstitial Lung Disease

Boehringer Ingelheim's Nintedanib Receives CHMP's Positive Opinion to Treat Systemic Sclerosis-Associated Interstitial Lung Diseas...

  • March 2, 2020
Genentech Collaborates with Imbio to Develop Imaging Diagnostics for Lung Diseases

    Genentech Collaborates with Imbio to Develop Imaging Diagnostics for Lung Diseases

    • October 9, 2020
    Verona Initiates P-III ENHANCE Studies Evaluating Nebulized Ensifentrine for the Maintenance Treatment of COPD

      Verona Initiates P-III ENHANCE Studies Evaluating Nebulized Ensifentrine for the Maintenance Treatment of COPD

      • September 24, 2020
      Genentech

        Genentech's Esbriet (pirfenidone) Receives FDA's Breakthrough Therapy Designation for Unclassifiable Interstitial Lung Disease

        • March 3, 2020
        Boehringer Ingelheim

          Boehringer Ingelheim's Nintedanib Receives CHMP's Positive Opinion to Treat Systemic Sclerosis-Associated Interstitial Lung Diseas...

          • March 2, 2020
          Boehringer Ingelheim Reports Results of OFEV (nintedanib) in P-III INBUILD Trial for Patients with Chronic Fibrosing Interstitial Lung Disease with Progressive Phenotype (1)

            Boehringer Ingelheim Reports Results of OFEV (nintedanib) in P-III INBUILD Trial for Patients with Chronic Fibrosing Interstitial...

            • October 10, 2019
            Bayer Collaborate with Women

              Bayer Collaborate with Women's Hospital and Massachusetts General Hospital to Launch Joint Lab Targeting Chronic Lung Diseases

              • September 24, 2019
              Image

              Incisive News in 3 Shots.

              Contact Us

              Our Information

              Follow Us

              Copyright © 2025 PharmaShots - All Rights Reserved.